InnovaRx Innova Health Strategies

Z34.81

Encounter for supervision of other normal pregnancy, first trimester

Billable FY2026 2025-10-01 → 2026-09-30
Exclusions 3 never code together
Z34code
Excludes1
  • any complication of pregnancy (O00-O9A)O00-O9A
  • encounter for pregnancy test (Z32.0-)Z32.0-
  • encounter for supervision of high risk pregnancy (O09.-)O09.-

Excludes1 — never code together. The excluded condition and this one are mutually exclusive.

Instructional notes 3
Z00-Z99chapter
Notes
  • Z codes represent reasons for encounters. A corresponding procedure code must accompany a Z code if a procedure is performed. Categories Z00-Z99 are provided for occasions when circumstances other than a disease, injury or external cause classifiable to categories A00-Y89 are recorded as 'diagnoses' or 'problems'. This can arise in two main ways:Z00-Z99A00-Y89
  • (a) When a person who may or may not be sick encounters the health services for some specific purpose, such as to receive limited care or service for a current condition, to donate an organ or tissue, to receive prophylactic vaccination (immunization), or to discuss a problem which is in itself not a disease or injury.
  • (b) When some circumstance or problem is present which influences the person's health status but is not in itself a current illness or injury.
Index entries leading here 1
Alongside this code 3 same parent — Z34.8
Medications 3

MED-RT files conditions by MeSH, which carves the world differently from ICD-10. These are name matches on this code's description, offered as candidates — not as an assertion that they are this code.

Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

Maps to no condition category in any loaded model.

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Parent
Z34.8
Block
Z30-Z39
Siblings
3

Present FY2024–FY2027.